Your browser doesn't support javascript.
loading
Bevacizumab at first recurrence after standard radio-chemotherapy is associated with improved overall survival in glioblastoma patients with large tumor burden.
Nguyen, Huy Tram; Nguyen, Nhung; Liu, Liang Yen; Dovek, Laura; Lenchner, Daniel; Harris, Robert; Ozer, Byram; Ravelo, Arliene; Sommer, Nicolas; Sim, Myung Shin; Elashoff, Robert; Green, Richard; Nghiemphu, Phioanh Leia; Cloughesy, Timothy Francis; Ellingson, Benjamin; Lai, Albert.
Afiliación
  • Nguyen HT; Department of Neurology, University of California, Los Angeles, California, USA.
  • Nguyen N; Department of Neurology, University of California, Los Angeles, California, USA.
  • Liu LY; Department of Neurology, University of California, Los Angeles, California, USA.
  • Dovek L; Department of Neurology, University of California, Los Angeles, California, USA.
  • Lenchner D; Department of Neurology, University of California, Los Angeles, California, USA.
  • Harris R; Department of Radiological Sciences and Biomedical Physics, University of California, Los Angeles, California, USA.
  • Ozer B; Department of Neurology, University of California, Los Angeles, California, USA.
  • Ravelo A; Genentech Inc, San Francisco, California, USA.
  • Sommer N; Genentech Inc, San Francisco, California, USA.
  • Sim MS; Department of Biomathematics, University of California, Los Angeles, California, USA.
  • Elashoff R; Department of Biomathematics, University of California, Los Angeles, California, USA.
  • Green R; Kaiser Permanente Southern California, Los Angeles, California, USA.
  • Nghiemphu PL; Department of Neurology, University of California, Los Angeles, California, USA.
  • Cloughesy TF; Department of Neurology, University of California, Los Angeles, California, USA.
  • Ellingson B; Department of Radiological Sciences and Biomedical Physics, University of California, Los Angeles, California, USA.
  • Lai A; Department of Neurology, University of California, Los Angeles, California, USA.
Neurooncol Pract ; 6(2): 103-111, 2019 Mar.
Article en En | MEDLINE | ID: mdl-31386050
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Neurooncol Pract Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Neurooncol Pract Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido